focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,166.00
Bid: 12,132.00
Ask: 12,136.00
Change: -6.00 (-0.05%)
Spread: 4.00 (0.033%)
Open: 12,180.00
High: 12,198.00
Low: 12,076.00
Prev. Close: 12,172.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Britain's FTSE recovers from Trump shock to hit one-week high

Wed, 09th Nov 2016 17:20

(ADVISORY- Follow European and UK stock markets in real time onthe Reuters Live Markets blog on Eikon, see cpurl://apps.cp./cms/?pageId=livemarkets)

* FTSE 100 index closes 1 pct higher

* Miners, pharma stocks rally

* U.S.-exposed firms also gain

By Atul Prakash and Kit Rees

LONDON, Nov 9 (Reuters) - Britain's top share index endedhigher, boosted by mining companies and drugmakers, after avolatile Wednesday that saw the index slumping 2 percent inearly trading following Donald Trump's victory in the U.S.presidential election.

Republican Trump stunned the world by defeating his heavilyfavored Democratic rival, Hillary Clinton, raising concerns thathis victory could cause economic and global uncertainty. Stocksacross the globe initially fell, but then recovered followinghis well-received victory speech.

"Overall, a Trump victory has so far failed to trigger theglobal stock market panic that many expected. As with Brexit,this is a cautionary reminder not to try to base investmentstrategies on the outcome of political events," Laith Khalaf,senior analyst at Hargreaves Lansdown, said.

Credit Suisse analysts said that most of Trump's moretroubling policies, such as those related to immigration andprotectionism, were likely to be toned down. Some of his otherpolicies, like more fiscal spending and lower corporate taxes,could be seen as positive for equities.

Mining companies tracked a sharp rise in prices of gold,generally seen as a safe-haven asset, although it was off itshighs after the conciliatory victory speech that also helped thedollar to rebound. Base metals also rallied on expectations thata Trump presidency could herald a period of fiscal stimulus andboost demand for metals.

The UK mining index, which includes preciousand base metals companies, surged 5.9 percent to its highestsince mid-2015, boosted by a 6.8 to 10.7 percent jump inFresnillo, Antofagasta and Glencore.

The blue chip FTSE 100 index closed 1 percent higherafter setting a one-week high. The domestically focused FTSE 250index closed 0.8 percent higher.

Healthcare stocks spiked in a relief rally as Clinton wasseen as imposing tighter regulations. Pharma stocks had beenlosing ground before the election on worries that a Clintonpresidency would put pressure on drug prices.

Shares in Hikma, Shire, Astrazeneca and GlaxoSmithKline gained 2.7 to 8.3 percent.

Some companies with significant exposure to the UnitedStates also rose. CRH a construction firm which had beentouted as a potential beneficiary from any increase in U.S.infrastructure spending, jumped 6 percent, as it derives abouthalf of its revenues from the country.

U.S.-focused Ashtead soared 11.5 percent.

Shares in banking stocks rose 1.3 percent, inline with their European peers, with some analysts speculatingabout a more benign regulation in America and on expectationsthat the Fed could still raise interest rates this year.

However, some stocks came under heavy selling pressure.British grocer Sainsbury fell 6.6 percent afterreporting an underwhelming set of results. The supermarketreported a third straight decline in first-half profit, hurt bya fall in sales. (Reporting by Kit Rees; Editing by Larry King)

More News
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
1 Dec 2023 08:52

LONDON MARKET OPEN: Miners give FTSE 100 boost thanks to China PMI

(Alliance News) - Stock prices in London opened higher on Friday, with the FTSE 100 boosted by mining stocks.

Read more
1 Dec 2023 08:33

AstraZeneca discontinues two phase III evidence trials for Lokelma

(Alliance News) - AstraZeneca on Friday said it has decided to discontinue the Stabilize-CKD and Dialize-outcomes phase III trials for Lokelma, citing increased enrolment timelines.

Read more
1 Dec 2023 08:01

AstraZeneca calls off two phase III trials into hyperkalaemia treatment

(Sharecast News) - Drugmaker AstraZeneca has called off two phase III trials on its hyperkalaemia treatment after a series of logistical challenges.

Read more
1 Dec 2023 07:41

LONDON BRIEFING: Stocks called higher; UK house prices fall annually

(Alliance News) - Stocks in London are called to open higher on Friday, following data from Nationwide showing that the annual pace of UK house price decline slowed in November.

Read more
27 Nov 2023 16:12

London close: Stocks start week in subdued state

(Sharecast News) - London's financial markets saw a somewhat subdued performance on Monday, as concerns regarding the Chinese economy cast a shadow over investor sentiment.

Read more
27 Nov 2023 09:20

LONDON BROKER RATINGS: Peel, Numis up Rightmove; Goldman cuts Entain

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
23 Nov 2023 18:41

IN BRIEF: AstraZeneca Chair Demare buys shares for over GBP200,000

AstraZeneca PLC - Cambridge-based pharmaceutical company - Chair Michel Demare buys 2,000 shares in total on Wednesday and Tuesday. Buys 1,000 shares for GBP101.05 each on Tuesday and 1,000 shares for GBP101.70 each on Thursday, for a total of GBP202,752.

Read more
20 Nov 2023 10:49

AstraZeneca launches new life sciences tech innovation firm Evinova

(Alliance News) - AstraZeneca PLC on Monday launched Evinova, a new health technology business focused on accelerating innovation across the life sciences sector, delivery of clinical trials and better health outcomes.

Read more
17 Nov 2023 15:20

London close: Stocks higher despite weaker retail sales data

(Sharecast News) - London's stock markets finished in a positive state on Friday despite weaker-than-expected UK retail sales figures.

Read more
17 Nov 2023 12:00

LONDON MARKET MIDDAY: Stocks shrug off downbeat UK retail sales

(Alliance News) - Stock prices in London were up at midday on Friday, as a week of favourable data as far as inflation goes gave investors a reason to overlook disappointing UK retail sales figures.

Read more
17 Nov 2023 09:03

LONDON MARKET OPEN: Stocks up despite UK retail sales growth miss

(Alliance News) - Stock prices in London opened higher on Friday, despite weaker-than-expected October retail sales figures for the UK.

Read more
17 Nov 2023 08:31

TOP NEWS: US approves AstraZeneca's Truqap for form of breast cancer

(Alliance News) - AstraZeneca PLC on Friday said that the US Food & Drug Administration approved its drug Truqap in combination with Faslodex to treat patients with an advanced form of breast cancer.

Read more
17 Nov 2023 07:58

LONDON BRIEFING: UK retail sales fall; AstraZeneca gets US approval

(Alliance News) - Stock prices in London are still set to open higher on Friday, despite October retail sales figures for the UK disappointing shortly before the opening bell.

Read more
17 Nov 2023 07:16

AstraZeneca gets US approval for breast cancer treatment

(Sharecast News) - AstraZeneca's 'Truqap', or capivasertib, in combination with 'Faslodex', or fulvestrant, has secured approval from the US Food and Drug Administration (FDA) for specific breast cancer treatments, the company announced on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.